The Advisory Council on the Misuse of Drugs is expected to propose the reclassification of Ecstasy (MDMA). At present, ecstasy is categorized as a Class A drug, alongside heroin and cocaine. The recommendation to downgrade the drug to Class B appears to be based on a principle of “relative harm.” Such reclassification may be seen as both radical and constructive, enabling drug workers, as well as the wider criminal justice system to take more appropriate action. However, early indications...
- An error has occurred, which probably means the feed is down. Try again later.
- ‘Doing family’ in adversity: exploring children’s and families’ experiences of alternative care in Thailand.
- Introducing a New Journal: Diversity & Inclusion Research
- Can young children give or withhold consent to heart surgery? Obstacles to innovative research
- How to make sense of the debate on “study drugs”?
- Earthquakes in Turkey: reflections from past experience
Subscribe to our alerts
Energy colonialism and the role of the global in local responses to new energy infrastructures in the UK
Video abstract for the paper by Susana Batel and Patrick Devine-Wright (University of Exeter) Read the paper here.